Detalhe da pesquisa
1.
Restrictive versus goal-directed fluid replacement strategy in ovarian cancer cytoreductive surgery (RiGoROCS): A randomised controlled trial.
Indian J Anaesth
; 67(12): 1101-1109, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343671